Emerging evidence indicates that ARTN is involved in the tumorigenesis, tumour metastasis and therapeutic resistance to cancers, such as mammary carcinoma, pancreatic adenocarcinoma and acute myeloid leukaemia. Here, ARTN is linked to acute myeloid leukemia.